These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37343601)

  • 41. Evaluation of the Technicon bound uricase method for the determination of uric acid in urine.
    Thomasson CG; Blijenberg BG; Leijnse B
    J Clin Chem Clin Biochem; 1982 May; 20(5):299-303. PubMed ID: 7108450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study.
    Sundy JS; Becker MA; Baraf HS; Barkhuizen A; Moreland LW; Huang W; Waltrip RW; Maroli AN; Horowitz Z;
    Arthritis Rheum; 2008 Sep; 58(9):2882-91. PubMed ID: 18759308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancing the Response Rate to Recombinant Uricases in Patients with Gout.
    Schlesinger N; Padnick-Silver L; LaMoreaux B
    BioDrugs; 2022 Mar; 36(2):95-103. PubMed ID: 35316517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypouricaemic effect after oral administration in chickens of polyethylene glycol-modified uricase entrapped in liposomes.
    Nishida Y; Kamatani N; Miyamoto T
    J Pharm Pharmacol; 1984 May; 36(5):354-5. PubMed ID: 6145782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uricase grafted nanoconducting matrix based electrochemical biosensor for ultrafast uric acid detection in human serum samples.
    Verma S; Choudhary J; Singh KP; Chandra P; Singh SP
    Int J Biol Macromol; 2019 Jun; 130():333-341. PubMed ID: 30797811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pegloticase and chronic gout.
    Ea HK; Chales G; Lioté F
    JAMA; 2011 Nov; 306(18):1979; author reply 1979-80. PubMed ID: 22068987
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of polyethylene glycol-modified uricase (PEG-uricase) to treat hyperuricemia in a patient with non-Hodgkin lymphoma.
    Chua CC; Greenberg ML; Viau AT; Nucci M; Brenckman WD; Hershfield MS
    Ann Intern Med; 1988 Jul; 109(2):114-7. PubMed ID: 3289428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phylogenetic Articulation of Uric Acid Evolution in Mammals and How It Informs a Therapeutic Uricase.
    Li Z; Hoshino Y; Tran L; Gaucher EA
    Mol Biol Evol; 2022 Jan; 39(1):. PubMed ID: 34718698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immobilization of uricase upon polypyrrole-ferrocenium film.
    Cete S; Yaşar A; Arslan F
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(6):607-20. PubMed ID: 18097787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy.
    Baraf HS; Yood RA; Ottery FD; Sundy JS; Becker MA
    J Clin Rheumatol; 2014 Dec; 20(8):427-32. PubMed ID: 25417679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of modification of a bacterial uricase with N-hydroxysuccinimide esters of succinate and carbonate of monomethoxyl poly(ethylene glycol).
    Zhang C; Yang X; Gao A; Hu X; Pu J; Liu H; Feng J; Liao J; Li Y; Liao F
    Biotechnol Appl Biochem; 2014; 61(6):683-90. PubMed ID: 24512141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Uric acid determination in dilute serum with an enzyme electrochemical and enzyme-free sensor].
    Jänchen M; Walzel G; Neef B; Wolf B; Scheller F; Kühn M; Pfeiffer D; Sojka W; Jaross W
    Biomed Biochim Acta; 1983; 42(9):1055-65. PubMed ID: 6670996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pegloticase (krystexxa) for treatment of refractory gout.
    Med Lett Drugs Ther; 2011 Feb; 53(1357):9-10. PubMed ID: 21304442
    [No Abstract]   [Full Text] [Related]  

  • 54. Evaluation of a kinetic uricase method for serum uric acid assay by predicting background absorbance of uricase reaction solution with an integrated method.
    Liao F; Zhao YS; Zhao LN; Tao J; Zhu XY; Liu L
    J Zhejiang Univ Sci B; 2006 Jun; 7(6):497-502. PubMed ID: 16691645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrochemical detection of uric acid via uricase-immobilized graphene oxide.
    Omar MN; Salleh AB; Lim HN; Ahmad Tajudin A
    Anal Biochem; 2016 Sep; 509():135-141. PubMed ID: 27402177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.
    Biggers K; Scheinfeld N
    Curr Opin Investig Drugs; 2008 Apr; 9(4):422-9. PubMed ID: 18393109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of the uricase-inhibited rat as an animal model in toxicology.
    Stavric B; Nera EA
    Clin Toxicol; 1978; 13(1):47-74. PubMed ID: 367691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An electrochemical biosensor based on multi-wall carbon nanotube-modified screen-printed electrode immobilized by uricase for the detection of salivary uric acid.
    Shi W; Li J; Wu J; Wei Q; Chen C; Bao N; Yu C; Gu H
    Anal Bioanal Chem; 2020 Oct; 412(26):7275-7283. PubMed ID: 32794003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of immobilized enzymes in automated clinical analysis: determination of uric acid and glucose using immobilized enzymes in column form.
    Endo J; Tabata M; Okada S; Murachi T
    Clin Chim Acta; 1979 Jul; 95(2):411-7. PubMed ID: 527227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of a uricase from Bacillus fastidious A.T.C.C. 26904 and its application to serum uric acid assay by a patented kinetic uricase method.
    Zhao Y; Zhao L; Yang G; Tao J; Bu Y; Liao F
    Biotechnol Appl Biochem; 2006 Sep; 45(Pt 2):75-80. PubMed ID: 16689679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.